Spatial mapping and senolytic targeting of senescent and disease-associated microglia in aged mouse brain white matter.
Abstract
Brain white matter undergoes structural and functional alterations linked to late-life cognitive decline, but the cellular and molecular basis of its selective vulnerability remains incompletely defined. Here, in naturally aged mice, we demonstrate that senescent and disease-associated microglia (DAM) phenotypes converge in hippocampal-adjacent white matter, particularly in the fimbria. Using regional gene expression profiling, immunolabeling, GeoMx digital spatial profiling and CosMx spatial molecular imaging, we identify an aged brain-exclusive microglial population concentrated in white matter that expresses DAM genes together with a 'SenBrain' senescence gene signature, including galectin-3 (GAL3/Lgals3). Single-cell spatial trajectory analyses suggest that multiple cell fate transitions may give rise to this aged, proinflammatory, senescent- and DAM-linked state. Pharmacogenetic or pharmacological senotherapeutic interventions reduced white matter GAL3
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The study identifies a specific senescent microglial population in aged mouse white matter driven by GAL3 and demonstrates that targeting this pathway reduces senescence markers. This work is relevant because it targets cellular senescence, a root cause of aging, rather than just treating downstream symptoms, but the impact is limited by its focus on a specific mouse model and a single biomarker without evidence of lifespan extension or comprehensive functional recovery.
Author of this paper? Send a correction.